ATE52093T1 - Pyrazolobenzoxazinderivate, ihre salze, verfahren und zwischenprodukte, verwendung als arzneimittel und diese enthaltende zubereitungen. - Google Patents
Pyrazolobenzoxazinderivate, ihre salze, verfahren und zwischenprodukte, verwendung als arzneimittel und diese enthaltende zubereitungen.Info
- Publication number
- ATE52093T1 ATE52093T1 AT86400427T AT86400427T ATE52093T1 AT E52093 T1 ATE52093 T1 AT E52093T1 AT 86400427 T AT86400427 T AT 86400427T AT 86400427 T AT86400427 T AT 86400427T AT E52093 T1 ATE52093 T1 AT E52093T1
- Authority
- AT
- Austria
- Prior art keywords
- carbon atoms
- alkyl
- group
- salts
- pyrazolobenzoxazine
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- VOYIDLDHIAMBPO-UHFFFAOYSA-N pyrazolo[3,4-h][1,2]benzoxazine Chemical class C1=NOC2=C3C=NN=C3C=CC2=C1 VOYIDLDHIAMBPO-UHFFFAOYSA-N 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000013067 intermediate product Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 7
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001270 agonistic effect Effects 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000000496 anti-anoxic effect Effects 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 230000003291 dopaminomimetic effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8503036A FR2578254B1 (fr) | 1985-03-01 | 1985-03-01 | Nouveaux derives de la pyrazolobenzoxazine, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant, et des intermediaires |
| EP86400427A EP0197807B1 (de) | 1985-03-01 | 1986-02-28 | Pyrazolobenzoxazinderivate, ihre Salze, Verfahren und Zwischenprodukte, Verwendung als Arzneimittel und diese enthaltende Zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE52093T1 true ATE52093T1 (de) | 1990-05-15 |
Family
ID=9316779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86400427T ATE52093T1 (de) | 1985-03-01 | 1986-02-28 | Pyrazolobenzoxazinderivate, ihre salze, verfahren und zwischenprodukte, verwendung als arzneimittel und diese enthaltende zubereitungen. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4661482A (de) |
| EP (1) | EP0197807B1 (de) |
| JP (1) | JPS61205281A (de) |
| AT (1) | ATE52093T1 (de) |
| CA (1) | CA1266648A (de) |
| DE (1) | DE3670493D1 (de) |
| FR (1) | FR2578254B1 (de) |
| HU (1) | HU194246B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2061179A1 (en) * | 1991-02-18 | 1992-08-19 | Ryuji Tsuzuki | Oxzazinobenzazole compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4198415A (en) * | 1979-01-22 | 1980-04-15 | Eli Lilly And Company | Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines |
| US4238486A (en) * | 1979-11-23 | 1980-12-09 | Merck & Co., Inc. | Indolobenzoxazines |
| US4552956A (en) * | 1984-08-15 | 1985-11-12 | Eli Lilly And Company | Partially hydrogenated pyrazolo, pyrimido and thiazolo[1,4]benzoxazines |
-
1985
- 1985-03-01 FR FR8503036A patent/FR2578254B1/fr not_active Expired
-
1986
- 1986-02-25 US US06/833,347 patent/US4661482A/en not_active Expired - Fee Related
- 1986-02-28 DE DE8686400427T patent/DE3670493D1/de not_active Expired - Fee Related
- 1986-02-28 CA CA000502944A patent/CA1266648A/fr not_active Expired - Fee Related
- 1986-02-28 HU HU86854A patent/HU194246B/hu not_active IP Right Cessation
- 1986-02-28 AT AT86400427T patent/ATE52093T1/de active
- 1986-02-28 JP JP61042074A patent/JPS61205281A/ja active Pending
- 1986-02-28 EP EP86400427A patent/EP0197807B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0197807A1 (de) | 1986-10-15 |
| HU194246B (en) | 1988-01-28 |
| FR2578254B1 (fr) | 1987-03-06 |
| US4661482A (en) | 1987-04-28 |
| CA1266648A (fr) | 1990-03-13 |
| FR2578254A1 (fr) | 1986-09-05 |
| DE3670493D1 (de) | 1990-05-23 |
| HUT40802A (en) | 1987-02-27 |
| EP0197807B1 (de) | 1990-04-18 |
| JPS61205281A (ja) | 1986-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1251209A (en) | DISHYDROPYRIDAZINONE DERIVATIVES | |
| ES523191A0 (es) | Procedimiento para la preparacion de 1-ariloxi-2,3,4,5-tetrahidro-3-benzazepinas | |
| ES8401961A1 (es) | Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas. | |
| DE3069813D1 (en) | Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation | |
| ES2000481A6 (es) | Procecimiento de preparacion de nuevos derivados del dihidro-2,3 benzofurano | |
| ATE56006T1 (de) | Succinimide derivate, herstellung und anwendung. | |
| HUP9801386A2 (hu) | Szerotonin 5-HT4 receptor parciális agonistáiként és antagonistáiként alkalmazható indazol-karboxamid-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények | |
| ES475173A1 (es) | Procedimiento para la fabricacion de quinazolinas. | |
| ATE59844T1 (de) | Indolcarboxamidderivate, ihre salze, verfahren und zwischenprodukte, anwendung als heilmittel und zusammensetzungen die sie enthalten. | |
| ATE15370T1 (de) | 3-piperidinyl-indole derivate, ihre salze, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende arzneimittel. | |
| ATE34385T1 (de) | Indol-ethylphenyl-derivate, ihre salze, vefahren zur herstellung, anwendung als heilmittel und zusammensetzungen die sie enthalten. | |
| ATE52093T1 (de) | Pyrazolobenzoxazinderivate, ihre salze, verfahren und zwischenprodukte, verwendung als arzneimittel und diese enthaltende zubereitungen. | |
| PH24709A (en) | Allylmercaptoacetylsydnonimines and pharmaceutical compositions thereof | |
| ATE8786T1 (de) | Indolobenzoxazinderivate, ihre salze, verfahren zur herstellung, ihre verwendung als arzneimittel und sie enthaltende zusammensetzungen. | |
| ATE81125T1 (de) | Benzimidazol-2-one-derivate, deren salze, verfahren und zwischenprodukte zu deren herstellung, deren anwendung als arzneimittel und sie enthaltende zusammensetzungen. | |
| DE3862660D1 (de) | 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel. | |
| ZA874970B (en) | Derivatives of 2,6-piperazinedione,their preparation processes and the pharmaceutical compositions containing them | |
| GR3007498T3 (de) | ||
| NZ218918A (en) | 4-oxo-1,4-dihydro-quinoline 3-carboxamides,their preparation and pharmaceutical compositions containing them | |
| ES2006336A6 (es) | Procedimiento de preparacion de nuevas acetamidas derivadas de la 2,3-dihidro-3-fenil-2-benzofuranona. | |
| ATE111465T1 (de) | Imidazobenzodiazepine und ihre salze, verfahren zur herstellung, verwendung als arzneimittel und diese substanzen enthaltende zusammensetzungen. | |
| ES2043631T3 (es) | Procedimiento de preparacion de hidroxialquilxantinas. | |
| GB8610369D0 (en) | Heterocyclic compounds | |
| DE3467297D1 (en) | Benzobicyclononane amino derivatives with anticonvulsive properties |